The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Open accessAbstract
The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been reported in single populations, with the majority of reports focused on White in Europe and North America. The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) has assembled data on 18,435 families with BRCA1 mutations and 11,351 families with BRCA2 mutations ascertained from 69 centers in 49 countries on six continents. This study comprehensively describes the characteristics of the 1,650 unique BRCA1 and 1,731 unique BRCA2 deleterious (disease-associated) mutations identified in the CIMBA database. We observed substantial variation in mutation type and frequency by geographical region and race/ethnicity. In addition to known founder mutations, mutations of relatively high frequency were identified in specific racial/ethnic or geographic groups that may reflect founder mutations and which could be used in targeted (panel) first pass genotyping for specific populations. Knowledge of the population-specific mutational spectrum in BRCA1 and BRCA2 could inform efficient strategies for genetic testing and may justify a more broad-based oncogenetic testing in some populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7112 · Cited by 2,954
Self-citationPARP inhibitors: Synthetic lethality in the clinic
Lord, C. J., & Ashworth, A. (2017) · Science · doi:10.1126/science.aam7344 · Cited by 2,880
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Pritchard, C. C., Mateo, J., Walsh, M. F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603144 · Cited by 1,680
Self-citationDomchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Self-citationProphylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Self-citationPrevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
Self-citationAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
Self-citationBRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Welcsh, P. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.705 · Cited by 648 · cited 1×
“These observed differences are largely because genomic rearrangements and missense mutations account for a much higher proportion of mutations in BRCA1 when compared with BRCA2 , as previously described (Welcsh & King, 2001).”
Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ögmundsdottir, H. M., & Eyfjörd, J. E. (1996) · Nature Genetics · doi:10.1038/ng0596-117 · Cited by 525
Self-citationAssociation of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
Rebbeck, T. R., Mitra, N., Wan, F., Sinilnikova, O. M., Healey, S., McGuffog, L., Mazoyer, S., Chenevix-Trench, G., Easton, D. F., Antoniou, A. C., et al. (2015) · JAMA · doi:10.1001/jama.2014.5985 · Cited by 521
Self-citationGayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-428 · Cited by 496
Self-citationGayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B. A. J., Stratton, M. R., & Easton, D. (1997) · Nature Genetics · doi:10.1038/ng0197-103 · Cited by 442
Self-citationGoldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, A. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 391
Self-citationNeuhausen, S. L., Godwin, A. K., Gershoni-Baruch, R., Schubert, E., Garber, J., Stoppa-Lyonnet, D., Olah, E., Csokay, B., Serova, O., Lalloo, F., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301885 · Cited by 335
Self-citationPrevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups
John, E. M., Miron, A., Gong, G., Phipps, A. I., Felberg, A., Li, F. P., West, D. W., & Whittemore, A. S. (2007) · JAMA · doi:10.1001/jama.298.24.2869 · Cited by 327
Self-citationFounder mutations in BRCA1 and BRCA2 genes
Ferla, R., Calò, V., Cascio, S., Rinaldi, G., Badalamenti, G., Carreca, I., Surmacz, E., Colucci, G., Bazan, V., & Russo, A. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm234 · Cited by 286
Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer
Górski, B., Byrski, T., Huzarski, T., Jakubowska, A., Menkiszak, J., Gronwald, J., Płużańska, A., Bębenek, M., Fischer-Maliszewska, Ł., Grzybowska, E., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302922 · Cited by 256
Self-citationNanda, R., Schumm, L. P., Cummings, S., Fackenthal, J. D., Sveen, L., Ademuyiwa, F., Cobleigh, M., Esserman, L., Lindor, N. M., Neuhausen, S. L., et al. (2005) · JAMA · doi:10.1001/jama.294.15.1925 · Cited by 250
Self-citationPerrin-Vidoz, L. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2805 · Cited by 246
Antoniou, A. C., Sinilnikova, O. M., Simard, J., Léoné, M., Dumont, M., Neuhausen, S. L., Struewing, J. P., Stoppa-Lyonnet, D., Barjhoux, L., Hughes, D. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/522611 · Cited by 241
Self-citationBRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Kurian, A. W. (2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328332dca3 · Cited by 200
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Thompson, E. R., Rowley, S. M., Li, N., McInerny, S., Devereux, L., Wong-Brown, M. W., Trainer, A. H., Mitchell, G., Scott, R. J., James, P. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.7454 · Cited by 183
Self-citationWeitzel, J. N., Clague, J., Martir-Negron, A. E., Ogaz, R., Herzog, J., Ricker, C. N., Jungbluth, C. R., Cina, C., Duncan, P. R., Unzeitig, G. W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0027 · Cited by 168
Self-citationPopulation Frequency of Germline BRCA1/2 Mutations
Maxwell, K. N., Domchek, S. M., Nathanson, K. L., & Robson, M. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.0554 · Cited by 164
Self-citationCIMBA, Chenevix-Trench, G., Milne, R. L., Antoniou, A. C., Couch, F. J., Easton, D. F., & Goldgar, D. E. (2007) · Breast Cancer Research · doi:10.1186/bcr1670 · Cited by 163
Self-citationOn the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations
Hamel, N., Feng, B., Foretová, L., Stoppa‐Lyonnet, D., Narod, S. A., Имянитов, Е. Н., Sinilnikova, O. M., Tihomirova, L., Lubiński, J., Gronwald, J., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.203 · Cited by 135
Self-citationPrevalence of BRCA1 Mutation Carriers among U.S. Non-Hispanic Whites
Whittemore, A. S., Gong, G. D., John, E. M., McGuire, V. M., Li, F. P., Ostrow, K. L., DiCioccio, R. A., Felberg, A., & West, D. W. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.2078.13.12 · Cited by 124
Self-citationAnczuków, O., Ware, M. D., Buisson, M., Zetoune, A. B., Stoppa‐Lyonnet, D., Sinilnikova, O. M., & Mazoyer, S. (2007) · Human Mutation · doi:10.1002/humu.20590 · Cited by 122
Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients
Rashid, M. U., Zaidi, A., Torres, D., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22269 · Cited by 122
Self-citationLang, G., Shi, J., Hu, X., Zhang, C., Shan, L., Song, C., Zhuang, Z., Cao, A., Ling, H., Yu, K., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30692 · Cited by 119
Bernstein, J. L., Teraoka, S. N., Southey, M. C., Jenkins, M. A., Andrulis, I. L., Knight, J. A., John, E. M., Lapinski, R. H., Wolitzer, A. L., Whittemore, A. S., et al. (2006) · Human Mutation · doi:10.1002/humu.20415 · Cited by 118
Self-citationGao, Q. C., Tomlinson, G. E., Das, S., Cummings, S. A., Sveen, L., Fackenthal, J. D., Schumm, L. P., & Olopade, O. I. (2000) · Human Genetics · doi:10.1007/s004390000290 · Cited by 108
Self-citationTorres, D., Rashid, M. U., Gil, F., Umaña, Á., Ramelli, G., Robledo, J. F., Tawil, M., Torregrosa, L., Briceño, I., & Hamann, U. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9370-1 · Cited by 106
Self-citationWeitzel, J. N., Lagos, V. I., Herzog, J., Judkins, T., Hendrickson, B. C., Ho, J. S., Ricker, C. N., Lowstuter, K. J., Blazer, K. R., Tomlinson, G. E., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0198 · Cited by 100
Self-citationOssa, C. A., & Torres, D. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0416 · Cited by 93
Self-citationVillarreal-Garza, C. M., Weitzel, J. N., Llacuachaqui, M., Sifuentes, E., Magallanes-Hoyos, M. C., Gallardo, L., Álvarez-Gómez, R. M., Herzog, J., Castillo, D., Royer, R., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3312-8 · Cited by 92
Self-citationA breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
Ramus, S. J., Friedman, L. S., Gayther, S. A., Ponder, B. A. J., Bobrow, L. G., van der Looji, M., Papp, J., & Oláh, E. (1997) · Nature Genetics · doi:10.1038/ng0197-14 · Cited by 82
Self-citationBRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia
Rodríguez, A. O., Llacuachaqui, M., Pardo, G. G., Royer, R., Larson, G. P., Weitzel, J. N., & Narod, S. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.10.027 · Cited by 78
Self-citationEMBRACE, Rebbeck, T. R., HEBON, Friebel, T. M., Mitra, N., Wan, F., Chen, S., Andrulis, I. L., Apostolou, P., Arnold, N., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0768-3 · Cited by 71
Self-citationDoes nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?
Ware, M. D., DeSilva, D., Sinilnikova, O. M., Stoppa‐Lyonnet, D., Tavtigian, S. V., & Mazoyer, S. (2005) · Oncogene · doi:10.1038/sj.onc.1209033 · Cited by 68
Reeves, M. D., Yawitch, T. M., van der Merwe, N. C., den Berg, H. J. V., Dreyer, G., & van Rensburg, E. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20186 · Cited by 65
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
Abugattas, J. E., Llacuachaqui, M., Allende, Y. S., Velásquez, A. A., Velarde, R. G., Cotrina, J. M., Garcés, M., León, M. L. V., Calderón, G., de la Cruz, M., et al. (2014) · Clinical Genetics · doi:10.1111/cge.12505 · Cited by 64
Self-citationBuisson, M., Anczuków, O., Zetoune, A. B., Ware, M. D., & Mazoyer, S. (2006) · Human Mutation · doi:10.1002/humu.20384 · Cited by 64
Bu, R., Siraj, A. K., Al‐Obaisi, K. A. S., Beg, S., Hazmi, M. A., Ajarim, D. S., Tulbah, A. M., Al‐Dayel, F., & Al-Kuraya, K. S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30143 · Cited by 64
Toh, G. T., Kang, P. C. E., Lee, S. S. W., Lee, D. S., Lee, S. Y., Selamat, S. A., Taib, N. A. M., Yoon, S., Yip, C. H., & Teo, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002024 · Cited by 55
Self-citationThe Icelandic founder mutation BRCA2 999del5: analysis of expression
Mikaelsdottir, E., Valgeirsdóttir, S., Eyfjord, J. E., & Rafnar, Þ. (2004) · Breast Cancer Research · doi:10.1186/bcr785 · Cited by 53
Vogel, K. J., Atchley, D. P., Erlichman, J., Broglio, K. R., Ready, K. J., Valero, V., Amos, C. I., Hortobagyi, G. N., Lu, K. H., & Arun, B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4703 · Cited by 52
Self-citationDouble Heterozygotes for the Ashkenazi Founder Mutations in BRCA1 and BRCA2 Genes
Friedman, E., Bruchim, R. B.-S., Сергеевна, К. А., Risel, S., Levy‐Lahad, E., Halle, D., Bar-On, E., Gershoni‐Baruch, R., Dagan, E., Kepten, I., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302040 · Cited by 51
Self-citationHaplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations
Laitman, Y., Feng, B., Zamir, I. N., Weitzel, J. N., Duncan, P. R., Port, D., Thirthagiri, E., Teo, S., Evans, D. G., Latif, A., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.124 · Cited by 50
Self-citationA multi-gene panel study in hereditary breast and ovarian cancer in Colombia
Cock-Rada, A. M., Ossa, C. A., García, H. I. G., & Gómez, L. R. M. (2017) · Familial Cancer · doi:10.1007/s10689-017-0004-z · Cited by 49
González‐Hormazábal, P., Gutiérrez‐Enríquez, S., Gaete, D., Reyes, J. M., Peralta, O., Waugh, E., Gómez, F., Margarit, S., Bravo, T., Blanco, R., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1170-y · Cited by 42
The impact of Converso Jews on the genomes of modern Latin Americans
Vélez, C. D., Palamara, P. F., Guevara‐Aguirre, J., Hao, L., Karafet, T. M., Guevara‐Aguirre, M., Pearlman, A. W., Oddoux, C., Hammer, M. F., Burns, E. R., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-1072-z · Cited by 41
The Role of the BRCA2 Gene in Susceptibility to Prostate Cancer Revisited
Ostrander, E. A., & Udler, M. S. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0556 · Cited by 38
Solano, A. R., Cardoso, F. C., Romano, V., Perazzo, F., Bas, C. A., Recondo, G., Santillán, F., González, E., Abalo, E., Viniegra, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10814 · Cited by 38
Self-citationOros, K., Ghadirian, P., Maugard, C. M., Perret, C., Paredes, Y., Mes‐Masson, A., Foulkes, W. D., Provencher, D. M., & Tonin, P. N. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00673.x · Cited by 36
Seong, M., Cho, S., Noh, D., Han, W., Kim, S., Park, C., Park, H., Kim, S., Kim, J. Y., & Park, S. S. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01202.x · Cited by 31
Self-citationEachkoti, R., Hussain, I., Afroze, D., AejazAziz, S., Jan, M., Shah, Z. A., Das, B. C., & Siddiqi, M. A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.08.012 · Cited by 22
Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore
Lee, A. S. G., Ho, G., Oh, P. C., Balram, C., Ooi, L. L., Lim, D. T. H., Wong, C. Y., & Hong, G. S. (2003) · Human Mutation · doi:10.1002/humu.9162 · Cited by 22
Self-citationA common Greenlandic Inuit BRCA1 RING domain founder mutation
Hansen, T. V. O., Ejlertsen, B., Albrechtsen, A., Bergsten, E. L., Bjerregaard, P., Hansen, T., Myrhøj, T., Nielsen, P. B., Wielenga, V. T., Andersen, M. K., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0060-z · Cited by 21
Self-citationHaplotype of the C61G BRCA1 Mutation in Polish and Jewish Individuals
Kaufman, B., Laitman, Y., Gronwald, J., Lubiński, J., & Friedman, E. (2009) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2009.0001 · Cited by 15
Self-citationSharifah, N. A., Nurismah, M. I., Lee, H.-C., Aisyah, A. N., Clarence-Ko, C. H., Naqiyah, I., Rohaizak, M., Ismail, F., Jamal, A. R. A., Latiff, Z. A., et al. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.04.010 · Cited by 13
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Cancer health disparities in racial/ethnic minorities in the United States
Zavala, V. A., Bracci, P. M., Carethers, J. M., Carvajal-Carmona, L., Coggins, N. B., Cruz-Correa, M. R., Davis, M., de Smith, A. J., Dutil, J., Figueiredo, J. C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01038-6 · Cited by 912
Self-citationEarly detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482
Unique roles of rare variants in the genetics of complex diseases in humans
Momozawa, Y., & Mizukami, K. (2021) · Journal of Human Genetics · doi:10.1038/s10038-020-00845-2 · Cited by 161
Direct-to-consumer genetic testing
Horton, R., Crawford, G., Freeman, L., Fenwick, A., Wright, C. F., & Lucassen, A. (2019) · BMJ · doi:10.1136/bmj.l5688 · Cited by 151
Metadata
- Authors
- Rebbeck, T. R., Friebel, T. M., Friedman, E., Hamann, U., Huo, D., Kwong, A., Olah, E., Olopade, O. I., Solano, A. R., Teo, S.-H., Thomassen, M., Weitzel, J. N., Chan, T., Couch, F. J., Goldgar, D. E., Kruse, T. A., Palmero, E. I., Park, S. K., Torres, D., van Rensburg, E. J., McGuffog, L., Parsons, M. T., Leslie, G., Aalfs, C. M., Abugattas, J., Adlard, J., Agata, S., Aittomäki, K., Andrews, L., Andrulis, I. L., Arason, A., Arnold, N., Arun, B. K., Asseryanis, E., Auerbach, L., Azzollini, J., Balmaña, J., Barile, M., Barkardottir, R. B., Barrowdale, D., Benitez, J., Berger, A., Berger, R., Blanco, A. M., Blazer, K. R., Blok, M. J., Bonadona, V., Bonanni, B., Bradbury, A. R., Brewer, C., Buecher, B., Buys, S. S., Caldes, T., Caliebe, A., Caligo, M. A., Campbell, I., Caputo, S. M., Chiquette, J., Chung, W. K., Claes, K. B. M., Collée, J. M., Cook, J., Davidson, R., de la Hoya, M., De Leeneer, K., de Pauw, A., Delnatte, C., Diez, O., Ding, Y. C., Ditsch, N., Domchek, S. M., Dorfling, C. M., Velazquez, C., Dworniczak, B., Eason, J., Easton, D. F., Eeles, R., Ehrencrona, H., Ejlertsen, B., EMBRACE, Engel, C., Engert, S., Evans, D. G., Faivre, L., Feliubadaló, L., Ferrer, S. F., Foretova, L., Fowler, J., Frost, D., Galvão, H. C. R., Ganz, P. A., Garber, J., Gauthier-Villars, M., Gehrig, A., Collaborators, G. S., Gerdes, A.-M., Gesta, P., Giannini, G., Giraud, S., Glendon, G., Godwin, A. K., Greene, M. H., Gronwald, J., Gutierrez-Barrera, A., Hahnen, E., Hauke, J., HEBON, Henderson, A., Hentschel, J., Hogervorst, F. B. L., Honisch, E., Imyanitov, E. N., Isaacs, C., Izatt, L., Izquierdo, A., Jakubowska, A., James, P., Janavicius, R., Jensen, U. B., John, E. M., Vijai, J., Kaczmarek, K., Karlan, B. Y., Kast, K., Investigators, K., Kim, S.-W., Konstantopoulou, I., Korach, J., Laitman, Y., Lasa, A., Lasset, C., Lázaro, C., Lee, A., Lee, M. H., Lester, J., Lesueur, F., Liljegren, A., Lindor, N. M., Longy, M., Loud, J. T., Lu, K. H., Lubinski, J., Machackova, E., Manoukian, S., Mari, V., Martínez-Bouzas, C., Matrai, Z., Mebirouk, N., Meijers-Heijboer, H. E. J., Meindl, A., Mensenkamp, A. R., Mickys, U., Miller, A., Montagna, M., Moysich, K. B., Mulligan, A. M., Musinsky, J., Neuhausen, S. L., Nevanlinna, H., Ngeow, J., Nguyen, H. P., Niederacher, D., Nielsen, H. R., Nielsen, F. C., Nussbaum, R. L., Offit, K., Öfverholm, A., Ong, K.-R., Osorio, A., Papi, L., Papp, J., Pasini, B., Pedersen, I. S., Peixoto, A., Peruga, N., Peterlongo, P., Pohl, E., Pradhan, N., Prajzendanc, K., Prieur, F., Pujol, P., Radice, P., Ramus, S. J., Rantala, J., Rashid, M. U., Rhiem, K., Robson, M., Rodriguez, G. C., Rogers, M. T., Rudaitis, V., Schmidt, A. Y., Schmutzler, R. K., Senter, L., Shah, P. D., Sharma, P., Side, L. E., Simard, J., Singer, C. F., Skytte, A.-B., Slavin, T. P., Snape, K., Sobol, H., Southey, M., Steele, L., Steinemann, D., Sukiennicki, G., Sutter, C., Szabo, C. I., Tan, Y. Y., Teixeira, M. R., Terry, M. B., Teulé, A., Thomas, A., Thull, D. L., Tischkowitz, M., Tognazzo, S., Toland, A. E., Topka, S., Trainer, A. H., Tung, N., van Asperen, C. J., van der Hout, A. H., van der Kolk, L. E., van der Luijt, R. B., Van Heetvelde, M., Varesco, L., Varon-Mateeva, R., Vega, A., Villarreal-Garza, C., von Wachenfeldt, A., Walker, L., Wang-Gohrke, S., Wappenschmidt, B., Weber, B. H. F., Yannoukakos, D., Yoon, S.-Y., Zanzottera, C., Zidan, J., Zorn, K. K., Hutten Selkirk, C. G., Hulick, P. J., Chenevix-Trench, G., Spurdle, A. B., Antoniou, A. C., & Nathanson, K. L.
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2018-03-12
- Volume
- 39
- Issue
- 5
- Pages
- 593-620
- ISSN
- 1059-7794 (ISSN-L)
- OpenAlex
- W2789006266
- Cited by
- 312
- References
- 65
- FWCI
- 19.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.